Cargando…
NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
The nucleotide oligomerization domain (NOD)-like receptors (NLRs) are a group of intracellular proteins that are essential for controlling the host's innate immune response. The cytosolic nucleotide binding oligomerization domains 1 and 2 receptors (NOD1 and NOD2) are the most widely investigat...
Autor principal: | Wang, Dongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576356/ https://www.ncbi.nlm.nih.gov/pubmed/36262606 http://dx.doi.org/10.1155/2022/2271788 |
Ejemplares similares
-
Retracted: NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
por: Intelligence and Neuroscience, Computational
Publicado: (2023) -
Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2
por: Zangara, Megan T., et al.
Publicado: (2021) -
A nod to the bond between NOD2 and mycobacteria
por: Dubé, Jean-Yves, et al.
Publicado: (2023) -
NOD1 and NOD2 Signaling in Infection and Inflammation
por: Moreira, Lilian O., et al.
Publicado: (2012) -
NOD1, NOD2, and NLRC5 Receptors in Antiviral and Antimycobacterial Immunity
por: Godkowicz, Magdalena, et al.
Publicado: (2022)